U.S., April 17 -- ClinicalTrials.gov registry received information related to the study (NCT07533344) titled 'Ga-68 PSMA PET/CT vs mpMRI in Cognitive Prostate Biopsy' on April 07.
Brief Summary: Prostate cancer is the most common malignancy among elderly men. With the routine use of prostate-specific antigen (PSA) testing since the 1980s, the incidence of prostate cancer has significantly increased. The diagnosis of prostate cancer is established through prostate biopsy, and several biopsy techniques have been developed in recent years.
Prostate biopsy can be broadly classified into systematic and targeted biopsy techniques. Systematic biopsy is performed under transrectal or transperineal ultrasound guidance without the use of prior imag...